Pfizer
PFE
$23.88
Share price
-0.50%
Change (1 day)
-12.88%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Total debt
Total debt on the balance sheet as of March 2025 : $61.29 Billion USD
According to Pfizer's latest financial reports the company's total debt is $61.29 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Pfizer - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $63.64 B | -10.16% |
| 2023-12-31 | $70.84 B | 103.23% |
| 2022-12-31 | $34.85 B | -5.78% |
| 2021-12-31 | $36.99 B | -3.33% |
| 2020-12-31 | $38.27 B | -24.72% |
| 2019-12-31 | $50.84 B | 21.79% |
| 2018-12-31 | $41.74 B | -2.02% |
| 2017-12-31 | $42.60 B | 3.76% |
| 2016-12-31 | $41.06 B | 5.56% |
| 2015-12-31 | $38.89 B | 6.04% |
| 2014-12-31 | $36.68 B | 0.53% |
| 2013-12-31 | $36.48 B | -2.59% |
| 2012-12-31 | $37.46 B | -3.81% |
| 2011-12-31 | $38.94 B | -11.56% |
| 2010-12-31 | $44.03 B | -9.51% |
| 2009-12-31 | $48.66 B | 181.56% |
| 2008-12-31 | $17.28 B | 31.54% |
| 2007-12-31 | $13.13 B | 64.65% |
| 2006-12-31 | $7.98 B | -55.51% |
| 2005-12-31 | $17.93 B | -3.28% |
| 2004-12-31 | $18.54 B | 27.26% |
| 2003-12-31 | $14.57 B | 23.41% |
| 2002-12-31 | $11.80 B | 33.1% |
| 2001-12-31 | $8.87 B | 63.93% |
| 2000-12-31 | $5.41 B | -23.48% |
| 1999-12-31 | $7.07 B | 117.23% |
| 1998-12-31 | $3.25 B | 9.41% |
| 1997-12-31 | $2.97 B | 1.85% |
| 1996-12-31 | $2.92 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $34.84 B | -43.15% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $52.25 B | -14.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $51.23 B | -16.40% | 🇺🇸 USA |
 Eli Lilly LLY | $38.51 B | -37.16% | 🇺🇸 USA |
 Novartis NVS | $31.27 B | -48.98% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $23.84 B | -61.09% | 🇬🇧 UK |
 Amgen AMGN | $57.38 B | -6.38% | 🇺🇸 USA |
 Abbott Laboratories ABT | $13.24 B | -78.39% | 🇺🇸 USA |
 AstraZeneca AZN | $31.29 B | -48.94% | 🇬🇧 UK |